Search Results for 'diabetic foot ulcers'

2 results found.

REMEDI enters agreement with US company to advance research into diabetic foot ulcers

REMEDI, The Regenerative Medicine Institute at NUI Galway and Orbsen Therapeutics have entered into an agreement with Cardium Therapeutics to utilise Cardium’s Excellagen® pharmaceutically-formulated gel as a delivery agent for Orbsen Therapeutics’ proprietary stromal cell therapy in pre-clinical studies for the potential treatment of diabetic foot ulcers.

Patients must foot the bill for home use blood treatment themselves, HSE tell consultants

New patients who want to avail of a home-use medical treatment which increases arterial blood flow to the leg must now foot the bill themselves.

 

Page generated in 0.0290 seconds.